Australia’s Kazia pays research institute $1.4M for epigenetic platform, preclinical drug
Kazia Therapeutics is paying $1.4 million upfront to secure a platform for generating epigenetic drugs from an Australian research institute.
Search fresh public links, source activity, and post angles for Garvan Institute.
Fresh curated links around Garvan Institute are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Kazia Therapeutics is paying $1.4 million upfront to secure a platform for generating epigenetic drugs from an Australian research institute.
Glencar has completed the Sidney Sussex Building, a 56,000 sq ft life sciences research and development facility at Chesterford Research Park.
A WA biotech duo, ProGenis and Syngenis Laboratories, is developing RNA-based therapies at the next frontier in diabetes medicine, while building Australia’s first RNA facility.
Scientists created a definitive E3 ligase atlas, resolving inconsistencies and enabling better disease research and drug design. Researchers at WEHI have led a large international...
The Translational Genomics Research Institute (TGen), a proud division of City of Hope, has unveiled a groundbreaking advancement in the field of precision oncology with the launch...
MGI Tech’s decade-long push helped turn sequencing into scalable, affordable global infrastructure. The post Building the Genome Grid appeared first on GEN - Genetic Engineering an...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.